Compare T-Rex 2X Long MSTR Daily Target ETF (MSTU) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
T-Rex 2X Long MSTR Daily Target ETF vs GeneDx Holdings Corp — how do they compare? T-Rex 2X Long MSTR Daily Target ETF trades at $30.42, while GeneDx Holdings Corp trades at $86.53 (market cap $2.58B). The key difference: GeneDx Holdings Corp is trading nearer its 52-week high, T-Rex 2X Long MSTR Daily Target ETF nearer its low. Which is the better fit depends on your goals.
| MSTU | WGS | |
|---|---|---|
Sector | Leveraged / Inverse | Technology |
52-Week High | $573.00 | $167.51 |
52-Week Low | $14.60 | $34.51 |
Market Cap | — | $2.58B |
Enterprise Value | — | $2.61B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MSTU trades at $33.31, down 8.64% today, with technical indicators showing a bullish trend supported by moving averages. The ETF recently underwent a 10:1 reverse stock split and declared a $0.29 dividend payable in August 2026. Recent news highlights significant trading activity as investors seek leveraged exposure to MicroStrategy amid Bitcoin volatility, though the fund has experienced substantial value erosion over the past year.
The outlook remains volatile given MSTU's leveraged structure, which compounds daily moves. While technical momentum appears positive, fundamental risks include the amplified exposure to MicroStrategy's performance and crypto market swings. Investors should weigh the potential for rapid gains against the documented risk of significant value erosion in leveraged products.
WGS trades at $85.87, down 0.14% on the day, with a bullish technical signal from moving averages and support at $84. The company reported Q2 2026 revenue of $114.4 million, beating estimates, and achieved adjusted profitability ahead of schedule. Recent news highlights partnerships and product launches, such as the NPC GenomeComplete initiative with Beren Therapeutics, driving positive sentiment.
Outlook is cautiously optimistic due to strong analyst support (90.9% buy ratings) and revenue growth, but risks include negative net income margins, high valuation multiples, and ongoing class action lawsuits. The stock's upside potential hinges on sustained operational improvements and market expansion in genomics diagnostics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About T-Rex 2X Long MSTR Daily Target ETF
MSTU is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bullish (long) position in MSTR, a company known for its significant Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on MSTU →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
